MB Chemotakas Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
34,158 |
- |
21,203 |
20,143 |
- |
0.60 |
0.07 |
100.00 |
58.97 |
20,349 |
1,360 |
0 |
21,709 |
2023 |
---|
28,472 |
- |
1,190 |
1,131 |
- |
0.75 |
0.03 |
100.00 |
3.97 |
21,480 |
559 |
0 |
22,039 |
2024 |
---|
2,500 |
- |
-15,065 |
-15,065 |
- |
2.57 |
0.00 |
100.00 |
-602.60 |
6,415 |
0 |
0 |
6,415 |
Register and
explore Okredo data2024 |
---|
2,500 |
- |
-15,065 |
-15,065 |
- |
2.57 |
0.00 |
100.00 |
-602.60 |
6,415 |
0 |
0 |
6,415 |
Register and
explore Okredo data2024
Turnover (€)
2,500 €-91 % *
Sales per employee (€)
-Profit before tax (€)
-15,065 €-1,366 % *
Net Profit (€)
-15,065 €-1,432 % *
Profit per employee (€)
-Working capital requirement
2.57 242.67 % *
Debt-to-equity ratio
0.00 -100.00 % *
Total profitability (%)
100.00 %0.00 % *
Net profitability (%)
-602.60 %-15,278.84 % *
Equity (€)
6,415 €-70 % *
Amounts Payable And Liabilities (€)
0 €-100 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
6,415 €-71 % *